Replies to post #234372 on Kraig Biocraft Laboratories Inc (KBLB)

[Money4Nothing-M4N]

Agreed. The OTC is a far bigger albatross than the RS ever was.

Get production to capacity and some more contracts signed and then do what it takes to jump exchanges.

I’m embarrassed to admit to some friends that I’ve invested a pretty good amount into penny land. Their IMMEDIATE reaction is “ARE YOU NUTS?!” In fact, that was MY immediate reaction to the person who introduced me to KBLB.

Honestly I’d have better luck getting them to come to an Amway meeting than investing in an OTC stock. Yes really.

I believe KBLB is a diamond in the ruff, but we gotta make some new friends!

[DimesForShares]

Biggest hurdle: prove production of a valuable material.

So far: commercial levels of production not yet attained, qualities of DS and MS are unknown to market.

Hope we are close on both accounts, but with KBLB, one never knows.

[Deannie]

Agreed that the OTC is a swamp. However, right now, Kim’s PRs are still quite speculative, vague at times and open to interpretation, thus appealing to highly risk-tolerant investors. Once real production is achieved and sales are booked, and something material comes of the patents, immunity worms, etc., PRs with real meat that new blood could easily understand and be attracted to can be released to industry publications and to general/mainstream media/news outlets where exposure will be gained that’ll generate new-blood investment interest that I don’t think we saw today. $550,000 traded today means it was probably a lot of people on this board adding to existing positions and some former shareholders who have come back to the table. JMHO, but I’m glad we closed above $.10. Let’s see if we can stay there until the next milestone is reached.